Julia G. Butchko, Chief Development Officer at Immunovant, Inc. (IMVT), sold 4,292 shares at $36.15 ($155K) on 2024-02-22, disclosed to the SEC on 2024-02-23.
Open-market sale of $155k IMVT by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.15 | 2,146 | $78K | 50.0% |
| 2 | $36.15 | 2,146 | $78K | 50.0% |
| Total | $36.15 avg | 4,292 | $155K | 100% |
| Filing → |
| IMVT | SELL | 2024-07-10 | $43K | — | Filing → |
| IMVT | SELL | 2024-05-24 | $193K | — | Filing → |
| IMVT | SELL | 2024-04-19 | $362K | — | Filing → |